Currently browsing tag


Illumina, partners make $100 million bet to detect cancer via blood test

By Julie Steenhuysen CHICAGO (Reuters) – Gene sequencing company Illumina Inc is going after the next big advance in cancer detection, working to develop a universal blood test to identify early-stage cancers in people with no symptoms of the disease. On Sunday, San Diego-based Illumina said it would form a new company, called Grail, with more than $100 million in Series A financing. Illumina will be the majority owner.

Some California winemakers accused of letting arsenic into products

By Alex Dobuzinskis LOS ANGELES (Reuters) – About 30 makers of low-priced California wines including popular brands Charles Shaw and Sutter Home allow unacceptable levels of arsenic in their products, private attorneys said in a proposed class action filed in Los Angeles on Thursday. The legal action represents a challenge to a segment of the industry that produces wines that consumers can buy for less than $10 a bottle, or in the case of Charles Shaw the so-called Two-Buck Chuck product that retailer Trader Joe’s has popularized at $2. The attorneys who brought the lawsuit said the majority of wineries in the state’s $23 billion wine industry, the nation’s largest, produce a safe product. “There is more regulation in the caramel corn industry in the United States than in the wine industry, as surprising as that is,” attorney Brian Kabateck told a news conference.